MI-EATON
24.5.2022 12:32:14 CEST | Business Wire | Press release
Power management company Eaton today announced its eMobility business has introduced a battery disconnect unit (BDU) that can be combined with upgraded Breaktor® circuit protection technology to provide circuit protection in electrified vehicles (EVs) while reducing overall complexity and cost.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220524005297/en/
When paired with the Breaktor circuit protection technology, which combines current switching and resettable bidirectional short-circuit protection with fast actuation, Eaton’s BDU eliminates the need for up to 15 additional system components. Traditional systems require a combination of pyro and thermal fuses and contactors.
“As manufacturers continue to increase the power levels in EVs, it’s increasingly important to have capable and dependable protection solutions,” said Kevin Calzada, global product strategy manager, Eaton’s eMobility business. “Our BDU combined with our Breaktor circuit protection technology provides everything needed, in a compact and efficient package, to protect the vehicle and occupants.”
The BDU’s primary function is to serve as an on/off switch to the battery depending on the mode the EV is operating in, such as charging or driving. Current model EVs rely on one of three traditional BDU configurations: fuse and contactor; pyro fuse and contactor; or fuse, pyro fuse and contactor, all used together in a single BDU. While all provide switching and protection functions, they each have disadvantages, including overall system complexity, serviceability, coordination difficulties and susceptibility to fatigue under high current levels.
Adding Breaktor circuit protection technology to Eaton’s BDU provides extra functionality and benefits, including active and passive actuation in a single device; the capability to transition to an off-state under a wide range of fault conditions; improved functional safety; the ability to be reset after a high-energy fault; and the ability to replace up to four high-voltage electrical components, which reduces complexity and system-level cost.
“Our Breaktor circuit protection technology’s self-triggering design, diagnostic electronics and mirror contact help achieve BDU functional safety goals,” Calzada said. “With its integrated coil driver, economizer, and the sensing/triggering circuit, Breaktor circuit protection technology also reduces battery management-system cost and complexity.”
Eaton’s Breaktor circuit protection technology also enables up to 350 kW DC fast charging when used to protect and switch the DC fast-charge circuit, allowing EVs to charge in 15 minutes or less. This capability is made possible by recent upgrades to the Breaktor circuit protection technology’s thermal management and materials to boost its power capacity. Breaktor circuit protection technology is now able to carry 500 amps continuously and up to 750 amps of continuous current when an active or passive cooling system is leveraged.
“Breaktor achieves best-in-class current ratings, and these can be even further increased with an appropriate cooling strategy,” Calzada said. “Eaton is able to design and develop a compatible cooling system to customer specifications and integrated into a BDU to meet these rising power requirements.”
Learn more about Eaton’s battery disconnect unit.
Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.
Founded in 1911, Eaton has been listed on the NYSE for nearly a century. We reported revenues of $19.6 billion in 2021 and serve customers in more than 170 countries. For more information, visit www.eaton.com . Follow us on Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005297/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
